Biophotonics Global Market Report 2023 – By Product (InVitro, InVivo), By Component (SeeThrough Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors, Other Applications), By End User (Diagnostics, Therapeutic, Tests, Other End Uses) – Market Size, Trends, And Global Forecast 2023-2032

The nanophotonic is focused on behavior of light on nanometer scale and also interaction of with light towards nanometersized objects. Nanophotonics or nano-optics is a part of nanotechnology that investigates the behavior of light on nanometer scales. The main products in nanophotonic market are LED, OLED, NFO, photovoltaic cells, optical amplifier, optical switches, holographic data storage system. LEDs in nanophotonic are used to control and manipulate the light flow. These are of various material such as quantum dots, photonic crystals, plasmonic, nanotubes, nanoribbons. They are used in different applications that include telecommunications, entertainment, consumer electronics, indicator and signs, lighting, non-visual applications, other applications The global nanophotonics market is segmented - 1) By Product: LED, OLED, NFO, Photovoltaic cells, Optical Amplifier, Optical Switches, Holographic Data Storage System 2) By Material: Quantum Dots, Photonic Crystals, Plasmonic, Nanotubes, Nanoribbons 3) By Application: Telecommunications, Entertainment, Consumer Electronics, Indicator And Signs, Lighting, Non-Visual Applications, Other Applications The global nanophotonics market size grew from $18.49 billion in 2022 to $24.82 billion in 2023 at a compound annual growth rate (CAGR) of 34.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The global nanophotonics market size is expected to grow to $77.99 billion in 2027 at a CAGR of 33.1%. The increasing demand for optical fibers and other telecommunication devices is driving the growth of the nanophotonic market. Adding nanoparticles to the optical fibers has allowed latest and most advanced features like improved refractive index, sensing, computation. For instance, according to IEEE, a professional association for electronic engineering and electrical engineering, India has an optical fiber-based network reaching 28 lakh (100,000) kilometers, compared to the National Broadband Mission's goal of deploying 50 lakh kilometers of optical fiber by 2024. This means that the country still has scope to install more optical fiber with rise in population. Hence, the demand for optical fiber will drive the growth of the nanophotonic market. Major players in the nanophotonic market are Carbon Solutions, Cambrios Technologies, Catalytic Materials, Cnano Technology, Cree, LG Display, Nanocs, Nanocyl, Nanoco Technologies, nanoPHAB, Nanosys, Nanostructured & Amorphous Materials, OSRAM Opto Semiconductors, Philips Lumileds Lighting, QD Vision, Quantum Materials, TCL Display Technology, Sharp Corporation, Novaled GmbH, IBM Corporation. The innovative nanophotonic-enabled products is a key trend gaining popularity in the nanophotonic market. The demand for nanophotonic-enabled produces has increased in the past few years. Nanophotonic-enabled products include LES, OLEDs and others. These nanophotonic enabled products are also used in biotechnology, nanomedicine and also in optical diagnostics. For example, in January 2021, Thorlabs Inc., an American privately held optical equipment company, announced the product release to the SPDC810 product line that is expected to cater to the rapidly expanding quantum photonics field. High-intensity photon sources are important for quantum photonics in various applications, from basic photon-matter interactions to device characterization. Therefore, designers employ a fully integrated 405 nm pump source that is adjustable at the front end of a spontaneous parametric down conversion (SPDC) device to generate photon pairs above 450 kHz at 810 nm. In July 2020, Jenoptik, a German integrated photonics group acquired Trioptics for an undisclosed amount. This acquisition is estimated to help the company consolidate its position in the photonics industry. Trioptics offers measuring and testing equipment for optical sensor and components. Asia-Pacific was the largest region in the nanophotonic market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the nanophotonic market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the nanophotonic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The nanophotonic market consists of sales of grating couplers, SOI electro-optical modulators, photonic crystals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The nanophotonic market research report is one of a series of new reports from The Business Research Company that provides nanophotonic market statistics, including nanophotonic industry global market size, regional shares, competitors with a nanophotonic market share, detailed nanophotonic market segments, market trends and opportunities, and any further data you may need to thrive in the nanophotonic industry. This nanophotonic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biotechnology services refer to the services that modify living microorganisms to provide biotechnology products on a contract or custom basis to medical, pharmaceutical, and scientific laboratories. They provide breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes. The main types of biotechnology services are prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, and research and development. Food biotechnology services encompass a diverse variety of technologies used in crops, livestock, forestry, fisheries and aquaculture, and agro-industry. They are used for a variety of purposes, including genetic improvement of plants and animals to increase yields or efficiency, characterization and conservation of genetic resources for food and agriculture, plant and animal disease diagnosis, vaccine development, and fermented food production. The various applications include pharmaceutical, biotechnological, academic, clinical trial, and healthcare sectors and are used by Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), and Contract Research and Manufacturing Services (CRAMS). The global biotechnology services market is segmented - 1) By Service: Prevention and Disease Control, Public Engagement Activities, Health Education and Research, Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing and Isolation, Research and Development 2) By Industry: Clinical Research Organizations (CROs), Contract Manufacturers Organizations(CMOs), Contract Research and Manufacturing Services (CRAMS) 3) By Area of Application: Pharmaceutical, Biotechnological, Academic, Clinical Trial, Healthcare Sectors The global biotechnology services market size will grow from $146.85 billion in 2022 to $163.71 billion in 2023 at a compound annual growth rate (CAGR) of 11.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the biotechnology services is expected to grow to $241.17 billion in 2027 at a CAGR of 10.2%. The increasing pervasiveness of conditions like hepatitis B, diabetes, and cancer is driving research in biotechnology. Biotechnology uses research tools from biology and chemistry to study the genetic material of bacteria and viruses to check the disease-producing agents. Oncology research is most prominent among biopharma companies. Stem cell treatment using a monoclonal antibody for therapy and genome sequencing is progressing in medical applications. According to the Indian Economic Survey 2021, the Indian biotechnology business is predicted to grow to US$ 150 billion by 2025. Global R&D spending by the world's largest publicly traded biotech companies increased by 13.7 percent each year, from $4.8 billion in 2001 to $55.0 billion in 2020. Therefore, the rising pervasiveness of diseases and huge expenses on R&D are predicted to contribute to the growth of the biotechnology services market. Major players in the biotechnology services market are Novartis, Fisher BioService, Pfizer, Novo Nordisk, BioAlps, Precision for Medicine, Sartorius and Aldevron. The risk related to genetic data is anticipated to limit the growth of the biotechnology services market. The biotechnological approach of transferring specially created genes for modification in characteristics to create genetically modified organisms (GMOs) has always been considered a threat to human and environmental health. According to the report of the World Conservation Union, there are numerous environmental risks likely to occur due to the use of GMOs, which include interbreeding, antibiotic resistance, impact on the ecosystem, creation of new or worse viruses, competition with natural species, unpredictable and unintended effects, and ethical concerns. The World Health Organization (WHO) has also set guidelines for manufacturers of GMO food. The National Bioengineered Food Disclosure Standard has been implemented in the USA since January 2020, making it mandatory to label all foods containing genetically engineered items as "bioengineered". Thus, the risk associated with genetically modified items is negatively impacting the growth of the biotechnology services market. Collaborations and partnerships between industry players are a growing trend in the field of biotech services. In January 2021, Novartis, a Switzerland-based pharmaceutical company collaborated with Alnylam, a US-based biopharmaceutical company for exploration in the application of the latter’s siRNA technology and the development of targeted therapy for the restoration of liver function. As part of the exclusive three-year research collaboration, Alnylam will develop and test potential siRNAs using Novartis' target-specific assays. Novartis will conduct further development and clinical research once a lead candidate has been identified. In October 2021, Amgen, a US-based biopharmaceutical company, acquired all outstanding shares of Teneobio for a deal amount of $2.5 billion. Amgen acquired Teneobio's bispecific and multispecific antibody technologies as part of the acquisition. These solutions complement the company's existing antibody expertise and BiTE platform. This will aid in the discovery and advancement of novel molecules for the treatment of a wide range of illnesses in Amgen's major treatment areas. TeneoBio is a US-based biotechnology business that specialises in the production of human heavy chain antibodies. Asia-Pacific was the largest region in the biotechnology services market in 2022. North America was the second largest region in the global biotechnology services market analysis. The regions covered in the global biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the biotechnology services market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in biotechnology. Numerous global issues are helped by biotechnology, including infectious diseases, ageing societies, food security, energy security, and climate change, to name a few. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products. The biotechnology services market research report is one of a series of new reports from The Business Research Company that provides biotechnology services market statistics, including biotechnology services industry global market size, regional shares, competitors with a biotechnology services market share, detailed biotechnology services market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology services industry. This biotechnology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical. The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration. The global healthcare nanotechnology market is segmented - 1) By Disease: Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases 2) By Type: Organic, Inorganic, Carbon-Based 3) By Application: Drug Delivery, Biomaterials, Active Implants, Tissue Regeneration The global healthcare nanotechnology market size will grow from $276.91 billion in 2022 to $316.3 billion in 2023 at a compound annual growth rate (CAGR) of 14.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the healthcare nanotechnology is expected to grow to $556.04 billion in 2027 at a CAGR of 15.1%. Increasing cancer disease cases are expected to propel the growth of the healthcare nanotechnology market. Nanotechnology is a promising mode of cancer treatment. This improving field of medical research can be used to discover better-personalized treatments for many diseases, including cancer. Globally, the prevalence of cancer is increasing. For instance, according to Globocan, in 2020, global cancer cases increased to 19.3 million cases and 10 million cancer deaths. Therefore, the increasing cancer disease cases are driving the healthcare nanotechnology market growth. Major players in the healthcare nanotechnology market are Pfizer Inc, Johnson & Johnson, Abbott Laboratories, Celgene Corporation, Merck & Company Inc.,, UCB (Union Chimique Belge) S.A, Teva Pharmaceutical Industries Ltd, Sanofi SA, Taiwan Liposome Company Ltd, GE Healthcare, Mallinckrodt plc, Leadiant Biosciences. Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. For instance, in July 2020, Nanowear, a US-based developer of a nanosensor technology for medical conditions and chronic disease, announced a partnership with Hackensack Meridian Health Systems. Their aim is to monitor confirmed or suspected COVID-19 patients with Nanowear’s cloth-based nanosensors, which can detect physiological and biomarker changes. Hackensack Meridian Health Systems is a US-based health care chain specializing in academic centers, acute care facilities, and research hospitals. In October 2020, Johnson & Johnson, a US-based healthcare company that develops and manufactures various pharma products, announced the acquisition of Momenta Pharmaceuticals for $6.5 billion. With this acquisition, Johnson & Johnson aims to further advance patient care in autoantibody-driven diseases. Momenta Pharmaceuticals is a UK-based company involved in biotechnology with an innovative scientific platform focused on discovering and developing novel biologic therapeutics. North America was the largest region in the healthcare nanotechnology market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the Healthcare Nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nanotechnology is the area of science and engineering concerned with designing, manufacturing, and deploying structures, devices, and systems by manipulating atoms and molecules at the nanoscale. Nanotechnology can provide significant advantages in terms of its application in emergency viral diseases, where phenomena that take place at dimensions in the nanometre scale are utilised in the design, characterisation, production and application of materials, structures, devices and systems. The main types of nanotechnology services are research and development, information tracking, technology scouting, standardization, regulatory briefings, and others. R&D is a process that aims to create new or improved technology that can provide a competitive advantage at the business, industry, or national levels. The services are used by various industries, including pharmaceuticals, medical equipment, food and beverages, IT, and others. The different providers include large enterprises as well as small and medium-sized enterprises. The global nanotechnology services market is segmented - 1) By Service: Research And Development, Information Tracking, Technology Scouting, Standardisation, Regulation Briefings, Other Services 2) By Application: Pharmaceuticals, Medical Equipment, Food and Beverages, IT, Other Applications 3) By Provider: Large Enterprise, Small and Medium Enterprise The global nanotechnology services market size will grow from $183.59 billion in 2022 to $203.16 billion in 2023 at a compound annual growth rate (CAGR) of 10.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global nanotechnology services is expected to grow to $291.05 billion in 2027 at a CAGR of 9.4%. The rise in investments from governments and companies in the field of nanotechnology has contributed to the growth of the nanotechnology services market. For instance, the investments under the National Nanotechnology Initiative (NNI) in US, a President’s 2021 Budget requested over $1.7 billion for the National Nanotechnology Initiative. Similarly, in 2020, National Institutes of Health (NIH), invested around $445 million in nanomedicine. The portal, Invest In Nano, debuted with a 2020 programme that would kick off a mission to connect breakthrough nanotechnology companies with investors. The rise in investments from governments and companies in the field of nanotechnology drove the growth of the nanotechnology services market. Major players in the nanotechnology services market are AdvanceTEC, Abbie Gregg, Inc. (AGI), BREC Solutions Limited, Cambridge Innovation Consulting (CamIn), EMC Service, Foley & Lardner, HDR, Ike Scientific, Innovationsgesellschaft and Intelligent Enclosures. The high cost of nanomaterials is expected to limit the nanotechnology services market. Nanoparticles are tiny particles that are smaller than the width of a strand of hair, and they can be found in a wide range of products, from drug-delivery devices to high-definition televisions. For instance, one milligramme of gold nanoparticles costs about $80, and for a gramme of gold nanoparticles, it is around $80,000. Nanotechnology is an expensive area of research and only developed nations have the resources to invest in it. The high cost of nanomaterials negatively impacts the nanotechnology services market as it discourages end-users from seeking services. The companies in the nanotechnology services market are focusing on its increasing application in the healthcare industry. Nanotechnology services can be used to innovate new generation of diagnostic and therapeutic modalities for important diseases. For example, in January 2023, ENTOD Pharmaceuticals, an India based pharmaceutical company, launched its new ocular aesthetic range focused on improving eye comfort and enhancing the aesthetics of the eyes. The Eyecirque range consists of the nanotechnology-based gel serum, under-eye skin brightening and anti-ageing tablets, lubricating eye drops and essential eye supplements. North America was the largest region in the nanotechnology services market in 2022. Western Europe was the second largest region in the global nanotechnology services market share. The regions covered in the global nanotechnology services market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nanotechnology services market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The nanotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in nanotechnology. Technology promises scientific advancement in a variety of fields, including medicine, consumer goods, energy, materials, and manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products. The nanotechnology services market research report is one of a series of new reports from The Business Research Company that provides nanotechnology services market statistics, including nanotechnology services industry global market size, regional shares, competitors with a nanotechnology services market share, detailed nanotechnology services market segments, market trends and opportunities, and any further data you may need to thrive in the nanotechnology services industry. This nanotechnology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cellular immunotherapy refers to a sort of immunotherapy in which a patient receives T cells, an immune cell, to aid the body in fighting diseases like cancer. It is a cutting-edge kind of treatment that uses the body's immune system to combat cancer. The main therapies of cellular immunotherapy are tumor-infiltrating lymphocyte (TIL) therapy, engineered T cell receptor (TCR) therapy, chimeric antigen receptor (CAR) T cell therapy, and natural killer (NK) cell therapy. Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy that involves extracting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro, and then infusing them back into patients to treat them. The various primary indications include b-cell malignancies, prostate cancer, renal cell carcinoma, liver cancer, non-Hodgkin lymphoma, and others, and are used for the treatment of prostate cancer, breast cancer, skin cancer, ovarian cancer, brain tumours, lung cancer, and others. The global cellular immunotherapy market is segmented - 1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, and Natural Killer (NK) Cell Therapy 2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin Lymphoma, Other Primary Indications 3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumour, Lung Cancer, Other Applications The global cellular immunotherapy market size grew from $4.3 billion in 2022 to $5.03 billion in 2023 at a compound annual growth rate (CAGR) of 17.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the cellular immunotherapy is expected to grow from $8.59 billion in 2027 at a CAGR of 14.3%. Increasing research and successful clinical trials in cellular immunotherapy are expected to drive the growth of the cellular immunotherapy market over the forecast period. Companies are focusing on developing new cellular immunotherapies for treating different diseases. For instance, in June 2022, according to a report published by the Cancer Research Institute, a US-based nonprofit organization devoted solely to developing immunotherapy for the prevention, treatment, and eventual eradication of all cancers, in the worldwide immuno-oncology pipeline as of April 2022, there were 2,756 active cell therapy drugs, up 36% from the landscape analysis of 2021 that revealed 2,031 such agents but also a slight slowdown from the 43% growth in the previous year. The rapid growth in the development of cellular immunotherapy in clinical and preclinical stages in 2020 as compared to that in 2019 is projected to expand the landscape of cellular immunotherapy. Subsequently, generating higher revenues for the growth of the cellular immunotherapy market. Major players in the cellular immunotherapy market are Novartis AG, Gilead Sciences Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC., JW CreaGene Co. Ltd., Green Cross Corp. (GC Pharma), AstraZeneca, Bristol-Myers Squibb, Pfizer Inc., and Roche. The high cost of cellular immunotherapies is anticipated to hinder cellular immunotherapy’s market growth. CAR-T therapy is a type of cellular immunotherapy and only two have been approved in the USA. The price of Yescarta and Kymriah is more than $350,000 per treatment in the USA, which is highly unaffordable for a majority of the patients, especially with low income. The high cost of cellular immunotherapies discourages patients to opt for this drug, thereby, impacting the demand and the market negatively. Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient's cells, as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast production, and quality control. For instance, in May 2022, Novartis AG, a Switzerland-based pharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of drugs, announced that after two or more lines of systemic therapy, the US Food and Drug Administration (FDA) has given expedited approval for Kymriah® (tisagenlecleucel) to treat adult patients with relapsed or refractory (r/r) follicular lymphoma (FL). In addition, Acepodia, a US-based next-generation cell immuno-technology company, will begin a phase 1 clinical trial in August 2020 to evaluate ACE1702, an allogeneic, off-the-shelf NK cell therapy, for the treatment of solid tumors. In April 2020, resTORbio, Inc., a US-based biopharmaceutical company specialising in the development and commercialization of drugs used for the treatment of aging-related diseases, merged with Adicet Bio, Inc., a biopharmaceutical company, for an undisclosed amount. Both the companies continue their operations as ‘Adicet Bio’. This merger is expected to help the companies advance allogeneic gamma-delta CAR-T cell therapy technology. Adicet Bio, Inc. is a US-based company specialising in the development of Adicet’s off-the-shelf allogeneic gamma delta T cell therapies for oncology and other indications. North America was the largest region in the cellular immunotherapy market in 2022. The regions covered in the global cellular immunotherapy market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the global cellular immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The cellular immunotherapy market includes revenues earned by entities by inventing, developing, administering, and understanding engineered immune effector cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply c either further along the supply chain or as part of other products. The cellular immunotherapy market research report is one of a series of new reports from The Business Research Company that provides cellular immunotherapy market statistics, including cellular immunotherapy industry global market size, regional shares, competitors with a cellular immunotherapy market share, detailed cellular immunotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the cellular immunotherapy industry. This cellular immunotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cellular/mobile telephone service refers to transmitting voice or non-voice messages over licensee's network in real-time only. The main types of cellular or mobile telephone services are basic communication and value-added. A basic communication services is retail telecommunications service that has a voice grade or equivalent transmission parameters and tone-dialing capability and provides with local exchange calling. The services provided includes 3G services, 4G services and 5G services and are used in manufacturing, energy and utilities, media and entertainment, IT and telecom, transportation and logistics and healthcare. The global cellular or mobile telephone services market is segmented - 1) By Type: Basic Communication, Value-Added 2) By Service: 3G Services, 4G Services, 5G Services 3) By End User: Manufacturing, Energy And Utilities, Media And Entertainment, It And Telecom, Transportation And Logistics, Healthcare The global cellular/mobile telephone services market size will grow from $213.15 billion in 2022 to $226.12 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global cellular/mobile telephone services is expected to grow to $281.03 billion in 2027 at a CAGR of 5.6%. An increasing number of mobile subscribers is predicted to contribute to the growth of the cellular or mobile telephone services market over the forecast period. According to the Cisco Annual Internet Report, the number of mobile subscribers across the globe is expected to increase to 5.7 billion (71% of the population) by 2023. According to data released by the Telecom Regulatory Authority of India (TRAI) in October 2020, Reliance Jio became the first mobile service provider to cross the 40 crore customers in India with the addition of over 35 lakh subscribers in July 2020. Therefore, growing mobile phone subscribers are projected to increase the overall demand for growth of the cellular or mobile telephone services market. Major players in the cellular or mobile telephone services market are AT&T Inc., Verizon, Deutsche Telekom, Vodafone, China Mobile Limited, Nippon Telegraph and Telephone Corporation, SoftBank Corp., IBM, CisCo., Alcatel-Lucent, Juniper Networks, Tata, Nokia, Alibaba Group Holdings Limited, Gemalto N.V., Google Inc. and KongZhong Corporation. During the forecast period, the high cost associated with value-added services is expected to limit the growth of the cellular or mobile telephone services market. For smartphone users keen on heavy streaming, mobile data does not always come cheap. The cost of a gigabyte of mobile data differs hugely between countries. For instance, UK-based price distinction website cable.co.uk released an analysis of 5 most expensive countries with average cost of 1GB of mobile data in 2022 that included Saint Helena at $41.06, the Falkland Islands at $38.45, São Tomé and Príncipe at $29.49, Tokelau at $17.88 and Yemen at $16.58 respectively. The mobile value-added services are some additional services offered to the customer by telecommunication operators at an additional charge, which are generally high and not affordable by common people subsequently affecting the revenues of cellular or mobile telephone services. The launch of the Fifth Generation (5G) networks is gaining popularity in the cellular or mobile telephone services market. The current fifth generation of mobile networks (5G) is a stimulant for the new industrial revolution because it offers much greater speed and bandwidth than previous networks along with low time for data travel or low latency. For instance, in February 2020, ETSI launched a new group for the fifth generation of Fixed Network (ETSI ISG F5G). The latest invention in cellular technology is Fifth-Generation (5G) networks, engineered to boost the speed of wireless networks. Using Fifth-Generation 5G networks, data is transmitted at the speed of 20 Gbps or more over wireless broadband connections exceeding speeds of other networks. 5G networks also provide a latency of 1 ms or lesser for uses that require real-time feedback. In January 2020, Samsung Group, a South Korea-based electronics company that sells mobile devices announced the acquisition of TeleWorld Solutions, Inc. for an undisclosed amount. With the acquisition of TeleWorld Solutions, Inc., Samsung is aiming to address end-to-end network support needs and accelerate 5G rollouts in the USA. TeleWorld Solutions, Inc. is a Virginia-based telecommunications provider of wireless networking and consulting services. Asia-Pacific was the largest region in the cellular or mobile telephone services market in 2022. North America was the second largest region of the global cellular or mobile telephone services market share. The regions covered in the global cellular or mobile telephone services market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cellular or mobile telephone services market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The cellular or mobile telephone services market includes revenues earned by providing cellular or mobile telephone services market by entities that provide radio communication between mobile and land stations, or between mobile stations, which can be classified into three groups: voice, SMS and MMS. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The cellular or mobile telephone services market research report is one of a series of new reports from The Business Research Company that provides cellular or mobile telephone services market statistics, including cellular or mobile telephone services industry global market size, regional shares, competitors with a cellular or mobile telephone services market share, detailed cellular or mobile telephone services market segments, market trends and opportunities, and any further data you may need to thrive in the cellular or mobile telephone services industry. This cellular or mobile telephone services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A cellular telephone is a telecommunications system in which a portable or mobile radio transmitter and receiver are linked through microwave radio frequencies to base stations that connect the user to a regular telephone network. The main product types of cellular telephones are smartphone and feature phones. Smartphones are advanced cellular phones with more functions similar to computer such as touchscreen surface, internet access, and operating system. The cellular telephone are used by various age-groups such as 18 years old, 18-45 years old, 45-60 years old, above 60 years old and it is distributed through OEM, retailer and e-commerce. The global cellular telephones market is segmented - 1) By Product Type: Smartphone, Feature Phone 2) By Age-Group: Under 18 Years Old, 18-45 Years Old, 45-60 Years Old, Above 60 Years Old 3) By Distribution channel: OEM, Retailer, E-commerce The global cellular telephones market size will grow from $399.85 billion in 2022 to $439.15 billion in 2023 at a compound annual growth rate (CAGR) of 9.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global cellular telephones is expected to grow to $623.23 billion in 2027 at a CAGR of 9.1%. Increase in disposable income is driving the cellular telephones market. Cellular telephones have now become a necessity in every household owing to advantages such as connectivity, productivity applications, entertainment and education and with increasing disposable income, individuals are increasingly buying smartphones. For instance, according to TRADING ECONOMICS, a US-based provider of economic indicators and financials, In the United States, disposable personal income increased from 18700.30 USD in August to 18771.60 USD in September of 2022. Rise in disposable income coupled with affordability increased the purchasing power of the individuals and in turn propelled the growth of the cellular telephones market. Major players in the cellular telephones market are Samsung Electronics Co. Ltd., Apple, Huawei, LG Electronics, Lenovo, Xiaomi, OPPO, Vivo, Motorola Mobility Holdings Inc, TCL Corporation, Research In Motion Limited, Sony Mobile Communications Inc., ZTE Corporation, Nokia, HTC Corporation, Others, Xiaomi, Gionee, LeEco/Coolpad, Micromax Informatics Ltd., and Ericsson. Uncertainty about government stabilities and policies affect imports of the raw materials required for manufacturing cellular telephone, creating a negative impact on the market. Uncertainties about government policies brought about by cancellation of trade agreements cause companies to decrease their import volumes to keep expenditures at the levels of previous years or to increase prices of finished products due to increased costs. For instance, the withdrawal of the USA from the Trans-Pacific Partnership (TPP) trade deal and the $250 billion tariffs on imported products from China by the US government affected the consumers and households indirectly thereby, hindering the growth of the cellular telephones market. Companies in the cellular telephones market are introducing technological advancements in processors that give the best customer experience. The smartphones are incorporated with 7nm (nanometer) processors that increase the speed of the device and have improved power efficiency and some are expected to support 5G technology as well. For instance, in 2021, Samsung launched their Galaxy F62 smartphones with 7nm Exynos 9825 processors to provide fast performance and power efficiency to young Gen Z and millennial customers. Asia-Pacific was the largest region in the cellular telephones market in 2022. Western Europe was the second largest region in the global cellular telephones market share. The regions covered in the global cellular telephones market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the cellular telephones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The cellular telephones market consists of sales of equipment such as cellular telephones, which use radio waves over a networked area (cells) and is served through a cell site or base station at a fixed location, enabling calls to transmit wirelessly over a wide range, to a fixed landline or via the internet. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The cellular telephones market research report is one of a series of new reports from The Business Research Company that provides cellular telephones market statistics, including cellular telephones industry global market size, regional shares, competitors with a cellular telephones market share, detailed cellular telephones market segments, market trends and opportunities, and any further data you may need to thrive in the cellular telephones industry. This cellular telephones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular diagnostics market consists of sales of molecular diagnostics services and related products by entities (organizations, sole traders, partnership) that are utilised to direct patient management, from diagnosis to treatment, especially in the treatment of congenital anomalies, infectious diseases, and cancer. Molecular diagnostic is a term used to describe a class of techniques that are used to examine biological markers in the genetic code (genome) of an organism and to determine how its cells express their genes as proteins. The main types of products in molecular diagnostics are instruments, reagents, consumables, software, and services. Instruments refer to a measuring device for determining the present value of a quantity under observation. The technologies include polymerase chain reaction (PCR), DNA sequencing, and next-generation sequencing, and these are used in oncology, pharmacogenomics, infectious diseases, genetic testing, neurological disease, cardiovascular disease, microbiology, and other applications. The various end-users are hospitals, laboratories, and other end-users (blood banks, home health agencies, and nursing homes). The global molecular diagnostics market size is expected to grow from $49.49 billion in 2021 to $49.64 billion in 2022 at a compound annual growth rate (CAGR) of 0.3%. The global molecular diagnostics market size is expected to decline to $47.78 billion in 2026 at a compound annual growth rate (CAGR) of -1.0%. The rising prevalence of infectious diseases and cancers of different forms drives the molecular diagnostics market. To determine whether mutations to a gene or chromosome may raise a person's chance of acquiring cancer or other disorders, molecular testing is employed. The increasing prevalence of infectious diseases and various types of cancer creates a demand for new diagnostic procedures, including fast and specific molecular diagnostic tests. For instance, in 2020, according to the National Cancer Institute, a US-based government agency, an estimated 1,806,590 new cases of cancer would be diagnosed in the United States and 606,520 people would die from the disease. Therefore, the increasing prevalence of cancer is driving the growth of the molecular diagnostic market. The advances in genomics and proteomics are a key trend gaining popularity in the molecular diagnostics market. Polymerase chain reaction (PCR) is a recent development in genomics and helps in discovering new approaches to molecular diagnosis for disease diagnosis and pathogenesis of diseases. This enables better monitoring and a fast diagnosis and major organizations are investing to have a competitive edge. Following the trend, $600 million to support the COVID-19 vaccine and therapy clinical trials led by the private sector and for Canadian bio-manufacturing opportunities. This announcement was part of the $1 billion Plan to Mobilize Science. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period. In April 2021, Hologic, a US-based women’s health technology company, acquired Mobidiag Oy for an undisclosed amount. The acquisition would accelerate the global growth of Mobidiag’s molecular diagnostic test platforms, which offer ease of use, multiplex capability, and rapid turnaround time. Mobidiag Oy is a Finland-based company that develops and provides molecular diagnostics for infectious diseases and antibiotic resistance. The major players in the molecular diagnostics market are Becton, BioMérieux SA, Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott, and Dickinson and Company. North America was the largest region in the molecular diagnostics market in 2021. The regions covered in the global molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the molecular diagnostics market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The global molecular diagnostics market is segmented - 1) By Technology: Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing 2) By Product: Instruments, Reagents and Consumables, Software and Services 3) By Application: Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Others 4) By End-User: Hospitals, Laboratories, and Others (Blood Banks, Home Health Agencies, and Nursing Homes)